Dignity Therapy/Life Plan in Patients with Pancreatic Cancer


  • Study type

  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • Rochester, Minnesota: 14-001857
    NCT ID: NCT02132325
    Sponsor Protocol Number: 14-001857

About this study

This study will evaluate feasibility and acceptability of providing the Dignity Therapy/Life Plan intervention to newly-diagnosed pancreatic cancer patients presenting for initial chemotherapy in the outpatient medical oncology setting. Investigators hypothesize that providing dignity therapy to this population will be feasible.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria

Inclusion Criteria:

  • Age >18
  • Undergoing initial chemotherapy for pancreatic adenocarcinoma (within 3 months of diagnosis)
  • English-speaking
  • Cognitively intact, per clinician judgment, as documented in electronic medical record (EMR)

Exclusion Criteria:

  • Currently receiving hospice or palliative care services
  • Concurrent diagnosis of delirium or dementia, per medical record
  • Diagnosis of major depression disorder, acute anxiety disorder or schizophrenia per medical record
  • Participating in other psychosocial intervention research studies.

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Ann Dose, Ph.D.

Open for enrollment

Contact information:

Adriana Delgado




Mayo Clinic Footer